SAMDaily.us | PRESOL | H | Using Transgenic Mouse to Generate Human Antibodies

SAMDAILY.US - ISSUE OF MAY 19, 2022 SAM #7475
SOLICITATION NOTICE

H -- Using Transgenic Mouse to Generate Human Antibodies

Notice Date: 5/17/2022 6:30:11 AM
Notice Type: Solicitation
NAICS: 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Contracting Office: CDC OFFICE OF ACQUISITION SERVICES ATLANTA GA 30333 USA
ZIP Code: 30333
Solicitation Number: 75D301-22-Q-74781
Response Due: 5/31/2022 2:00:00 PM
Archive Date: 06/15/2022
Point of Contact: Joseph Gugumuck, Phone: 7037127645
E-Mail Address: qna4@cdc.gov
(qna4@cdc.gov)
Description: CDC seeks to test a transgenic mouse model that is engineered with human immunoglobulin gene segments to produce humanized antibodies, with the goal of determining if the antibodies generated from that mouse model can better recapitulate the antibody repertoire from humans. �� Overall objective is to provide the Influenza Division with transgenic mice that express human antibody repertoire, which would be useful for assessing the efficacy of CVVs and developing antibodies.
Web Link: SAM.gov Permalink
(https://sam.gov/opp/b69837c6d9fa4e25aead542e58e922cf/view)
Place of Performance: Address: Atlanta, GA 30329, USA; Zip Code: 30329; Country: USA
Record: SN06329166-F 20220519/220517230101 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |